细胞凋亡
化学
线粒体
癌症研究
癌细胞
细胞生物学
内质网
肺癌
细胞器
未折叠蛋白反应
下调和上调
抗药性
癌症
纳米医学
自噬
活性氧
程序性细胞死亡
内源性凋亡
姜黄素
药物输送
纳米载体
体内
多重耐药
硼替佐米
细胞色素c
联合疗法
谷胱甘肽
细胞毒性
肺癌的治疗
药理学
化疗
药品
转染
毒品携带者
氧化应激
作者
Jiachang Lin,Pei Huang,Yongqi Wang,Jiaxiang Wu,Yushi Jian,Lin Zhu,Huaying Wen,Wenhui Gao,Yingling Miao,Hao Wang,Xiyong Yu,Chunfang Liu,Yi Zhou
标识
DOI:10.1021/acs.molpharmaceut.5c01528
摘要
The intrinsic resistance of tumor cells to apoptosis frequently results in chemoresistance and therapeutic failure in clinical settings. The main active ingredients of traditional Chinese medicine, in combination with chemotherapy drugs, have become one of the effective treatment methods to overcome this kind of drug resistance by targeting double subcellular organelles to promote apoptosis. In this study, we developed a Cu 2+ -coordinated paeoniflorin (PF)/doxorubicin (DOX) biocomplex, referred to as PCD, with the aim of overcoming cellular apoptosis resistance for combinational lung cancer therapy. PCD demonstrates remarkable water solubility and superior in vivo biocompatibility. Owing to the coordination effect, the self-assembled PCD exhibits a nanoscale particle size, a narrow and homogeneous grain distribution, as well as exceptional dispersion stability. Furthermore, PCD has the potential to disassemble under conditions of high glutathione levels and low pH, thereby facilitating effective drug release. PF-mediated endoplasmic reticulum stress (ERS) can downregulate the expression of FDX1 and DLAT proteins. Ca 2+ overload induced by ERS disrupts mitochondrial matrix ion balance, accelerates water efflux, and ultimately leads to mitochondrial volume reduction and a decrease in mitochondrial membrane potential. Ultimately, this process synergizes with DOX-induced reactive oxygen species production to enhance apoptosis in lung cancer cells. PCD exhibits significant superiority over monotherapy in inhibiting tumor growth while minimizing systemic toxicity via enhanced induction of lung cancer apoptosis. This study may provide a promising avenue for advancing self-delivery nanomedicine to overcome apoptosis resistance in lung cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI